By Michael Dabaie


Baxter International Inc. and Moderna Inc. said they are in an agreement for Baxter BioPharma Solutions to provide fill/finish sterile manufacturing services and supply packaging for about 60 million to 90 million doses of the Moderna Covid-19 Vaccine in 2021.

Baxter's BioPharma Solutions business is a contract manufacturing organization that specializes in injectable pharmaceuticals, including vaccines.

The manufacturing of the Moderna Covid-19 vaccine would take place at the BioPharma Solutions fill/finish sterile manufacturing facilities in Bloomington, Ind.

The companies didn't disclose additional details of the agreement.


Write to Michael Dabaie at


(END) Dow Jones Newswires

March 08, 2021 09:32 ET (14:32 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.